Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-12-13
2009-02-17
Desai, Rita J (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S326000, C546S194000, C546S218000
Reexamination Certificate
active
07491735
ABSTRACT:
The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR5. These compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).
REFERENCES:
patent: 5021409 (1991-06-01), Murrer
patent: 5583131 (1996-12-01), Bridger
patent: 5698546 (1997-12-01), Bridger
patent: 5817807 (1998-10-01), Bridger
patent: 6001826 (1999-12-01), Murrer
patent: 6159990 (2000-12-01), Lagu et al.
patent: 6319932 (2001-11-01), Nerenberg et al.
patent: 6365583 (2002-04-01), MacFarland
patent: 0 747 357 (2002-01-01), None
patent: 1 219 605 (2002-07-01), None
patent: WO-96/40136 (1996-12-01), None
patent: WO-00/56729 (2000-09-01), None
patent: WO-01/25200 (2001-04-01), None
patent: WO-02/22599 (2002-03-01), None
patent: WO-02/22600 (2002-03-01), None
patent: WO-02/34745 (2002-05-01), None
patent: WO-03/042178 (2003-05-01), None
Thoma, et. al. “Orally Bioavailable Competitive CCR5 Antagonists” Journal of Medicinal Chemistry 2004, 47, 1939-1955.
Martin, Yvonne C. et. al. “Do Structurally Similar Molecules Have Similar Biological Activity?” Journal of Medicinal Chemistry 2002, 45, 4350-4358.
David R. Lide, ed., CRC Handbook of Chemistry and Physics, 88th Edition (Internet Version 2008), “http://www.hbcpnetbase.com” CRC Press/Taylor and Francis, Boca Raton, FL. “Definitions of Scientific Terms” “aryl groups” Section 2, p. 30.
“aryl” Hawley's Condensed Chemical Dictionary, 14th Edition Hawley's Condensed Chemical Dictionary, 14th Edition, 2002, Wiley online.
General Chemistry Glossary, online “http://antoine.frostburg.edu/cgi-bin/senese/searchglossary.cgi?query=aryl&shtml=%2Fchem” defines “aryl”.
A. D. McNaught and A. Wilkinson “Compendium of Chemical Terminology” “aryl”, The Gold Book, Second Edition “http://old.iupac.org/publications/compendium/index.html” Blackwell Science, 1997.
Pozharskii et. al. Heterocycles in Life and Society Wiley, 1997, pp. 1-6.
Abi-Younes et al., Circ. Res. (2000) 86:131-138.
Aiuti et al., J. Exp. Med. (1997) 185:111-120.
Alkhatib et al., Science (1996) 272:1955-1958.
Arai et al., Eur. J. Haematol. (2000) 64:323-332.
Arenburg et al., J. Leukocyte Biol. (1997) 62:554-562.
Balashov et al., PNAS USA (1999) 96:6873-6878.
Blaak et al., Proc. Natl. Acad. Sci. USA (2000) 97:1269-1274.
Blanco et al., Antimircrobial. Agents and Chemother. (2000) 44:51-56.
Bleul et al., J. Exp. Med. (1998) 187:753-762.
Bleul et al., Nature (1996) 382:829-833.
Bradstock et al., Leukemia (2000) 14:882-888.
Bridger et al., Advances in Antiviral Drug Design, vol. 3, E. De Clercq (Ed.), JAI press (1999) pp. 161-229.
Bridger et al., J. Med. Chem. (1999) 42:3971-3981.
Burger et al., Blood (1999) 94:3658-3667.
Carroll et al., Science (1997) 276:273-276.
Cocchi et al., Science (1995) 270:1811-1815.
Connor and Ho, J. Virol. (1994) 68:4400-4408.
Deng et al., Nature (1996) 381:661-666.
Donzella et al., Nature Medicine (1998) 4:72-77.
Dragic et al., Nature (1996) 381:667-673.
Egberink et al., J. Virol. (1999) 73:6346-6352.
Eitner et al., Transplantation (1998) 66:1551-1557.
Fedyk et al., J. Leukocyte Biol. (1999) 66:667-673.
Feng et al., Science (1996) 272:872-877.
Gerard et al., Natl. Immunol. (2001) 2(2):108-115.
Gonzalo et al., J. Immunol. (2000) 165:499-508.
Gupta et al., J. Biolog. Chem. (1998) 7:4282-4287.
Ishii et al., J. Immunol. (1999) 163:3612-3620.
Lataillade et al., Blood (1999) 95:756-768.
Liu et al., Cell (1996) 86:367-377.
Luster, New Eng. J. Med. (1998) 338(7):436-445.
Maekawa et al., Internal Medicine (2000) 39:90-100.
Michael et al., J. Virol. (1998) 72:6040-6047.
Michael et al., Nature Med. (1997) 3:338-340.
Miedema et al., Immune, Rev. (1994) 140:35.
Moore et al., J. of Invest. Med. (1998) 46:113-120.
Moore et al., Trends Cardiovasc. Med. (1998) 8:51-58.
Murdoch et al., Blood (2000) 95:3032-3043.
Murphy et al., Pharmacol. Rev. (2000) 52(1):145-176.
Nagasawa et al., Nature (1996) 382:635-638.
Nagase et al., J. Immunol. (2000) 164:5935-5943.
Nanki et al., J. Immunol. (2000) 164:5010-5014.
Oberlin et al., Nature (1996) 382:833-835.
Obrien et al., Lancet (1997) 349:1219.
Panzer et al., Transplantation (2004) 78(9):1341-1350.
Peled et al., Blood (2000) 95:3289-3296.
Peled et al., Science (1999) 283:845-848.
Ponath, Exp. Opin. Invest. Drugs (1998) 7:1-18.
Ma et al., Immunity (1999) 10:463-471.
Rana et al., J. Virol. (1997) 71:3219-3227.
Robinson et al., Cancer Res. (2003) 63(23):8360-8365.
Salcedo et al., Am. J. Pathol. (1999) 154:1125-1135.
Samson et al., Nature (1996) 382:722-725.
Schols et al., Anitviral Research (1997) 35:147-156.
Schols et al., J. Exp. Med. (1997) 186:1383-1388.
Schuitemaker et al., J. Virol. (1992) 66:1354-1360.
Seghal et al., J. Surg. Oncol. (1998) 69:99-104.
Simmons et al., J. Virol. (1996) 70:8355-8360.
Simmons et al., J. Virol. (1998) 72:8453-8457.
Szekanecz et al., Seminars in Immunology (2003) 15:15-21.
Tachibana et al., Nature (1998) 393:591-594.
Tan et al., Expert Opin. Investig. Drugs (2003) 12(11):1765-1776.
Tersmette et al., J. Virol. (1988) 62:2026-2032.
Theodorou et al., Lancet (1997) 349:1219-1220.
Viardot et al., Ann. Hematol. (1998) 77:195-197.
Wyatt et al., Science (1998) 280:1884-1888.
Xia et al., J. Neurovirology (1999) 5:32-41.
Yssel et al., Clinical and Experimental Allergy (1998) 28:104-109.
Yun et al., Circulation (2004) 109(7):932-937.
Zhang et al., AIDS Res. Hum. Retroviruses (1997) 13:1357-1366.
Zhang et al., J. Virol. (1998) 72:9307-9312.
Zhang et al., J. Virol. (1999) 73:3443-3448.
Zou et al., Nature (1998) 393:591-594.
Databse CAPLUS on STN, No. 49:17187, accession No. 1955:17187.
International Search Report for PCT/US04/41865, mailed on Oct. 14, 2005, 3 pages.
Mensonides-Harsema et al., J. Med. Chem. (2000) 43:432-439.
International Search Report for PCT/US06/22897, date mailed on Mar. 29, 2007, 4 pages.
Bogucki David
Bourque Elyse
Bridger Gary J.
Di Fluri Maria R.
Langille Jonathan
Desai Rita J
Genzyme Corporation
Morrison & Foerster / LLP
O'Dell David K
LandOfFree
Chemokine receptor binding compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemokine receptor binding compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemokine receptor binding compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4120504